Dendritic Cell Vaccines Extend CD19 CAR-T Cell Persistence and Improve the Outcomes in Refractory/Relapsed Adult B-ALL

Category Primary study
JournalBlood
Year 2023
This article has no abstract
Epistemonikos ID: d5aceb6ef074c1b846d137ad4e73c68967de491a
First added on: Feb 17, 2025